Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.29 Analyst target: $1.99 Upside: 587.74%
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases in the UK and internationally. The company is headquartered in London, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.